Working… Menu

Risk Assessment of Febrile Neutropenia and Grade 3-4 Neutropenia in Patients With Non-hematological Cancer Treated With Conventional Chemotherapy (NEURISK)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01799421
Recruitment Status : Completed
First Posted : February 26, 2013
Last Update Posted : November 21, 2016
Information provided by (Responsible Party):
Asociación para el Fomento de la Investigación y el Desarrollo Integral de la Oncología

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2014
Actual Study Completion Date : December 2015